Venmax Drugs and Pharmaceuticals Ltd Approves Amendment to Capital Clause in Amalgamation Scheme

Venmax Drugs and Pharmaceuticals Ltd, a company engaged in the trading of Nutraceuticals products and Drug Intermediates & Cosmetic Chemicals, announced that its Board of Directors approved the amendment in Para 2.2 of the Share Capital Clause in the Draft Scheme of Amalgamation with Hatri Pharma Private Limited. The amendment pertains to the Issued, Subscribed & Paid-Up Capital of Venmax Drugs and Pharmaceuticals Ltd. The company has issued 1,00,25,000 (One Crore Twenty-Five Thousand) convertible equity share warrants, out of which 63,44,000 equity shares have been allotted to warrant holders pursuant to conversion of warrants and the balance 36,81,000 equity shares are pending allotment upon conversion. This amendment would result in an increase in the issued, subscribed and paid-up equity share capital of the company upon exercise of the warrants by the holders.